The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects May Be a Result of Elevated Factor VIII Levels
Overview
Affiliations
In a large retrospective study of thrombophilic families, we analyzed 405 relatives of patients, hypothesizing that hyperhomocysteinemia and elevated factor VIII levels are closely related. Median factor VIII levels in hyperhomocysteinemic relatives were 169 IU/dL, compared with 136 IU/dL in normohomocysteinemic relatives (p =0.007), and were more often elevated (>150 IU/dL; p =0.006). Hyperhomocysteinemia was associated with an increased risk of venous and arterial thrombosis; relative risk (RR) 2.6 (CI 1.3-4.8) and 3.7 (CI 1.5-8.4) respectively. Relatives with elevated FVIII were also at risk; RR 2.3 (CI 1.4-4.0) for venous thrombosis and 2.3 (CI 1.0-5.1) for arterial thrombosis. After excluding all relatives with elevated factor VIII, RR for hyperhomocysteinemia and venous thrombosis dropped to 1.3 (CI 0.2-9.8) and no relatives had arterial thrombosis. We conclude that it is likely that the increased risk of venous and arterial thrombosis in hyperhomocysteinemia is mainly related to elevated FVIII levels.
Hereditary thrombophilia as a possible risk factor for severe disease in COVID-19: a case series.
Tse J, Gongolli J, Prahlow J Forensic Sci Med Pathol. 2024; .
PMID: 39331315 DOI: 10.1007/s12024-024-00879-4.
Homocysteine levels, H-Hypertension, and the MTHFR C677T genotypes: A complex interaction.
Al Hageh C, Alefishat E, Ghassibe-Sabbagh M, Platt D, Hamdan H, Tcheroyan R Heliyon. 2023; 9(6):e16444.
PMID: 37274647 PMC: 10238895. DOI: 10.1016/j.heliyon.2023.e16444.
Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats.
da Cunha A, Scherer E, da Cunha M, Schmitz F, Machado F, Lima D Mol Cell Biochem. 2011; 360(1-2):205-14.
PMID: 21948259 DOI: 10.1007/s11010-011-1058-0.
Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients.
Agorasti A, Mourvati E, Trivellas T, Papadopoulos V, Bazntiara I, Christoforidou A Int Urol Nephrol. 2011; 44(2):523-33.
PMID: 21387085 DOI: 10.1007/s11255-011-9926-9.